Sarepta Therapeutics believes that collaborative working relationships between healthcare professionals (“HCPs”), healthcare organizations (“HCOs”), patient advocacy organizations (“PAOs”), and life sciences companies are critical for the advancement of patient care and the development of innovative medicines.  Therefore, Sarepta Therapeutics is committed to complying with all applicable laws and regulations that promote transparency wherever it is conducting business and will disclose payments and other transfers of value made to HCPs, HCOs, and PAOs in accordance with such applicable laws, regulations, and the rules of the associations that it is a member of. Details of these transfers of value can be found below.


Sweden Disclosure report
Methodological Note (English)
Methodological Note (Swedish)

The Netherlands

The Netherlands R&D Disclosure report